Precigen Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PGEN Nasdaq 2836 https://precigen.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Precigen Inc

Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting - Apr 24th, 2024 2:20 pm
Actym Therapeutics Appoints Thomas Smart as CEO - Apr 24th, 2024 1:00 pm
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th - Mar 28th, 2024 8:05 pm
Precigen, Inc. (NASDAQ:PGEN) Q4 2023 Earnings Call Transcript - Mar 20th, 2024 2:07 pm
Precigen Inc (PGEN) Reports Full Year 2023 Financial Results - Mar 19th, 2024 9:31 pm
Precigen Reports Full Year 2023 Financial Results and Business Updates - Mar 19th, 2024 8:05 pm
Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis - Mar 12th, 2024 8:05 pm
Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th - Mar 5th, 2024 9:05 pm
Precigen, Inc. (NASDAQ:PGEN): When Will It Breakeven? - Feb 20th, 2024 6:22 pm
Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference - Feb 6th, 2024 9:05 pm
Insider Stock Buying Reaches US$1.72m On Precigen - Feb 4th, 2024 12:44 pm
Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission - Jan 16th, 2024 1:05 pm
Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference - Jan 8th, 2024 1:30 pm
Even after rising 15% this past week, Precigen (NASDAQ:PGEN) shareholders are still down 86% over the past three years - Dec 27th, 2023 2:16 pm
Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference - Dec 18th, 2023 9:05 pm
Precigen to Participate in the JMP Securities Hematology and Oncology Summit - Nov 29th, 2023 9:05 pm
Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs - Nov 9th, 2023 9:55 pm
Precigen to Participate in the Stifel 2023 Healthcare Conference - Nov 7th, 2023 9:05 pm
While institutions own 26% of Precigen, Inc. (NASDAQ:PGEN), private equity firms are its largest shareholders with 37% ownership - Sep 25th, 2023 3:03 pm
Precigen to Participate in Upcoming Leading Investor and Industry Conferences - Sep 19th, 2023 8:05 pm